These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 7747316)

  • 41. Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen.
    Luo C; Chintu C; Bhat G; Raviglione M; Diwan V; DuPont HL; Zumla A
    Tuber Lung Dis; 1994 Apr; 75(2):110-5. PubMed ID: 8032043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania.
    Borgdorff MW; Barongo LR; Klokke AH; Newell JN; Senkoro KP; Velema JP; Gabone RM
    Genitourin Med; 1995 Aug; 71(4):212-5. PubMed ID: 7590710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC; Abdulmumini T; Robinson S; Rook GA; Stanford JL
    Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High mortality rates among patients with tuberculosis in Bangui, Central African Republic.
    Garin B; Glaziou P; Kassa-Kelembho E; Yassibanda S; Mbelesso P; Morvan J
    Lancet; 1997 Nov; 350(9087):1298. PubMed ID: 9357415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
    Mwinga A; Nunn A; Ngwira B; Chintu C; Warndorff D; Fine P; Darbyshire J; Zumla A;
    Lancet; 2002 Oct; 360(9339):1050-5. PubMed ID: 12383985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis.
    Pablos-Méndez A; Sterling TR; Frieden TR
    JAMA; 1996 Oct; 276(15):1223-8. PubMed ID: 8849749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
    Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ
    N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa.
    Connolly C; Reid A; Davies G; Sturm W; McAdam KP; Wilkinson D
    AIDS; 1999 Aug; 13(12):1543-7. PubMed ID: 10465079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up.
    Kang'ombe C; Harries AD; Banda H; Nyangulu DS; Whitty CJ; Salaniponi FM; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 2000; 94(3):305-9. PubMed ID: 10975007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.
    Hawken MP; Meme HK; Elliott LC; Chakaya JM; Morris JS; Githui WA; Juma ES; Odhiambo JA; Thiong'o LN; Kimari JN; Ngugi EN; Bwayo JJ; Gilks CF; Plummer FA; Porter JD; Nunn PP; McAdam KP
    AIDS; 1997 Jun; 11(7):875-82. PubMed ID: 9189212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
    Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recruitment to a trial of tuberculosis preventive therapy from a voluntary HIV testing centre in Lusaka: relevance to implementation.
    Godfrey-Faussett P; Baggaley R; Mwinga A; Hosp M; Porter J; Luo N; Kelly M; Msiska R; McAdam K
    Trans R Soc Trop Med Hyg; 1995; 89(4):354-8. PubMed ID: 7570860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.
    Skevaki CL; Kafetzis DA
    Paediatr Drugs; 2005; 7(4):219-34. PubMed ID: 16117559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.
    Fitzgerald DW; Desvarieux M; Severe P; Joseph P; Johnson WD; Pape JW
    Lancet; 2000 Oct; 356(9240):1470-4. PubMed ID: 11081529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The point of view of a high prevalence country: Malawi.
    Nyangulu DS
    Bull Int Union Tuberc Lung Dis; 1991 Dec; 66(4):173-4. PubMed ID: 1687509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.
    Quigley MA; Mwinga A; Hosp M; Lisse I; Fuchs D; Porter JDH ; Godfrey-Faussett P
    AIDS; 2001 Jan; 15(2):215-22. PubMed ID: 11216930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire.
    Mukadi YD; Wiktor SZ; Coulibaly IM; Coulibaly D; Mbengue A; Folquet AM; Ackah A; Sassan-Morokro M; Bonnard D; Maurice C; Nolan C; Kreiss JK; Greenberg AE
    AIDS; 1997 Jul; 11(9):1151-8. PubMed ID: 9233463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association of tuberculosis and HIV infection in Harare, Zimbabwe.
    Houston S; Ray S; Mahari M; Neill P; Legg W; Latif AS; Emmanuel J; Bassett M; Pozniak A; Tswana S
    Tuber Lung Dis; 1994 Jun; 75(3):220-6. PubMed ID: 7919316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.